OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction
Ágnes Juhász, Susan Markel, Shikha Gaur, et al.
Journal of Biological Chemistry (2017) Vol. 292, Iss. 19, pp. 7866-7887
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui, Jing‐Quan Wang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2018) Vol. 41, pp. 1-25
Closed Access | Times Cited: 556

NADPH oxidases and ROS signaling in the gastrointestinal tract
Gabriella Aviello, Ulla G. Knaus
Mucosal Immunology (2018) Vol. 11, Iss. 4, pp. 1011-1023
Open Access | Times Cited: 187

The Role of Oxidative Stress and Its Counteractive Utility in Colorectal Cancer (CRC)
Debasish Basak, Mohammad N. Uddin, Jake Hancock
Cancers (2020) Vol. 12, Iss. 11, pp. 3336-3336
Open Access | Times Cited: 148

Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells
Yongxia Zhao, Xiaochun Ye, Zhifeng Xiong, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 796-796
Open Access | Times Cited: 80

NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors
Alessandra Cipriano, Monica Viviano, Alessandra Feoli, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 11632-11655
Open Access | Times Cited: 54

NOX5: Molecular biology and pathophysiology
Rhian M. Touyz, Aikaterini Anagnostopoulou, Francisco J. Rios, et al.
Experimental Physiology (2019) Vol. 104, Iss. 5, pp. 605-616
Open Access | Times Cited: 100

Reactive Oxygen Species (ROS), Intimal Thickening, and Subclinical Atherosclerotic Disease
Denise Burtenshaw, Michael Kitching, Eileen M. Redmond, et al.
Frontiers in Cardiovascular Medicine (2019) Vol. 6
Open Access | Times Cited: 100

Epigenetics/epigenomics and prevention by curcumin of early stages of inflammatory‐driven colon cancer
Renyi Wu, Lujing Wang, Ran Yin, et al.
Molecular Carcinogenesis (2019) Vol. 59, Iss. 2, pp. 227-236
Open Access | Times Cited: 97

Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study
Tetsuo Shoda, Margaret H. Collins, Mark Rochman, et al.
Gastroenterology (2022) Vol. 162, Iss. 6, pp. 1635-1649
Open Access | Times Cited: 38

Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression
Xiaoming Li, H. Michael Shepard, Jessica Cowell, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 19, pp. 4798-4807
Open Access | Times Cited: 80

Crosstalk between Rac1-mediated actin regulation and ROS production
Alejandro Acevedo, Christian González‐Billault
Free Radical Biology and Medicine (2018) Vol. 116, pp. 101-113
Closed Access | Times Cited: 76

The Double-Edged Sword Profile of Redox Signaling: Oxidative Events As Molecular Switches in the Balance between Cell Physiology and Cancer
Sonia Emanuele, Antonella D’Anneo, Giuseppe Calvaruso, et al.
Chemical Research in Toxicology (2018) Vol. 31, Iss. 4, pp. 201-210
Closed Access | Times Cited: 63

Growth of breast cancer cells by leptin is mediated via activation of the inflammasome: Critical roles of estrogen receptor signaling and reactive oxygen species production
Pawan Kumar Raut, Sang‐Hyun Kim, Dong Young Choi, et al.
Biochemical Pharmacology (2019) Vol. 161, pp. 73-88
Closed Access | Times Cited: 62

Inhibiting the Activity of NADPH Oxidase in Cancer
Mariam M. Konaté, Smitha Antony, James H. Doroshow
Antioxidants and Redox Signaling (2020) Vol. 33, Iss. 6, pp. 435-454
Open Access | Times Cited: 56

Malic enzyme 1 (ME1) in the biology of cancer: it is not just intermediary metabolism
Frank A. Simmen, Iad Alhallak, Rosalia C. M. Simmen
Journal of Molecular Endocrinology (2020) Vol. 65, Iss. 4, pp. R77-R90
Open Access | Times Cited: 54

NOX as a Therapeutic Target in Liver Disease
Deyamira Matuz‐Mares, Héctor Vázquez‐Meza, María Magdalena Vilchis‐Landeros
Antioxidants (2022) Vol. 11, Iss. 10, pp. 2038-2038
Open Access | Times Cited: 30

A paradoxical role of reactive oxygen species in cancer signaling pathway: Physiology and pathology
Vaikundamoorthy Ramalingam, R. Rajaram
Process Biochemistry (2020) Vol. 100, pp. 69-81
Closed Access | Times Cited: 49

NOX Inhibitors: From Bench to Naxibs to Bedside
Mahmoud H. Elbatreek, Hermann AM Mucke, Harald Schmidt
Handbook of experimental pharmacology (2020), pp. 145-168
Closed Access | Times Cited: 47

NOX2-Derived Reactive Oxygen Species in Cancer
Hanna Grauers Wiktorin, Ebru Aydin, Kristoffer Hellstrand, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-15
Open Access | Times Cited: 43

Molecular insights of NADPH oxidases and its pathological consequences
Bhargav N. Waghela, Foram U. Vaidya, Yashika Agrawal, et al.
Cell Biochemistry and Function (2020) Vol. 39, Iss. 2, pp. 218-234
Closed Access | Times Cited: 42

Nuclear translocation of Atox1 potentiates activin A-induced cell migration and colony formation in colon cancer
Arundhati Jana, Archita Das, Nancy Krett, et al.
PLoS ONE (2020) Vol. 15, Iss. 1, pp. e0227916-e0227916
Open Access | Times Cited: 41

Microenvironmental Reactive Oxygen Species in Colorectal Cancer: Involved Processes and Therapeutic Opportunities
Maria Alba Sorolla, Iván Astola Hidalgo, Anabel Sorolla, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5037-5037
Open Access | Times Cited: 35

Inhibiting NADPH Oxidases to Target Vascular and Other Pathologies: An Update on Recent Experimental and Clinical Studies
Anthony L. Sylvester, David X. Zhang, Sophia Ran, et al.
Biomolecules (2022) Vol. 12, Iss. 6, pp. 823-823
Open Access | Times Cited: 27

Harnessing cell-surface CD26 proteolysis-targeting chimeras for molecular targeted therapy against non-small cell lung cancer
Qiuyu Gong, Guangjian Zhang, Bohao Liu, et al.
Research Square (Research Square) (2025)
Closed Access

Page 1 - Next Page

Scroll to top